Search Results - Justine Adams
- Showing 1 - 2 results of 2
-
1
A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice by Ian R. Woodcock, George Tachas, Nuket Desem, Peter J. Houweling, Michael Kean, Jaiman Emmanuel, Rachel Kennedy, Kate Carroll, Katy de Valle, Justine Adams, Shireen R. Lamandé, Chantal Coles, Chrystal Tiong, Matthew Burton, Daniella Villano, Peter Button, Jean-Yves Hogrel, Sarah Catling-Seyffer, Monique M. Ryan, Martin B. Delatycki, Eppie M. Yiu
Published in PLoS ONE (2024-01-01)Get full text
Article -
2
Survival in Duchenne muscular dystrophy in Australia: a 50 year retrospective cohort studyResearch in context by Zoe E. Davidson, Suzanna Vidmar, Amanda Griffiths, Mark E. Howard, David J. Berlowitz, Elizabeth F. Jones, Tim Scully, Darran Treanor, Bikram Singh, David Prior, Matilde G. Frost, Robin Forbes, Natassja Billich, Justine Adams, Kate Carroll, Tuqa Al Lawati, Hannah Bourne, Andrew J. Kornberg, Monique M. Ryan, Ian R. Woodcock, Eppie M. Yiu, Michael M.H. Cheung
Published in The Lancet Regional Health. Western Pacific (2025-05-01)Get full text
Article